Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)

BACKGROUND: The conventional treatment options for advanced gastric patients remain unsatisfactory in terms of response rate, response duration, toxicity, and overall survival benefit. The purpose of this phase II study was to evaluate the activity and safety of cetuximab combined with cisplatin and...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Pinto, C, Di Fabio, F, Barone, C, Siena, S, Falcone, A, Cascinu, S, Rojas Llimpe, F L, Stella, G, Schinzari, G, Artale, S, Mutri, V, Giaquinta, S, Giannetta, L, Bardelli, A, Martoni, A A
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Nature Publishing Group 2009
Θέματα:
Clinical Study
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2768436/
https://ncbi.nlm.nih.gov/pubmed/19773760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605319
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια